Related Experiment Video
Updated: Jun 13, 2026

08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
First CD123-targeted ADC secures FDA approval for rare blood cancer
Nature Reviews. Drug Discovery
|June 11, 2026
Abstract
No abstract available in PubMed .
